Indica Labs’ Webinar | Deployment of HALO AP at Neogenomics – Next Generation Digital Pathology Software for the Modern Anatomic Pathology Lab

.

Deployment of HALO AP at NeoGenomics:
Next Generation Digital Pathology Software for
the Modern Anatomic Pathology Lab
16 June, 2020
8:00 PDT | 11:00 EDT | 16:00 BST

REGISTER

Indica Labs is proud to introduce our HALO AP, state-of-the-art anatomic pathology software designed to support a variety of collaborative and quantitative workflows for clinical pathology labs, including remote slide review, tumor boards, secondary consultations, clinical trials, qualitative and quantitative scoring.

In this webinar, Indica Labs’ HALO AP Product Manager, Eric Runde, will discuss these capabilities and the nationwide deployment of HALO AP for quantitative IHC testing for breast cancer and colorectal cancer panels at NeoGenomics. Dr. Sally Agersborg, Medical Director at NeoGenomics, will discuss considerations when selecting an image analysis platform and approaches to validation of image analysis for a multi-site laboratory.

Who should attend?

Pathologists, technicians, lab managers, and medical directors at CROs, reference labs, hospitals, and pathology groups.

Learning Objectives

Digital pathology workflows for hospitals, reference labs, and clinical CROs.
Collaborative workflows for tumor boards and consultations.
Deployment and validation of quantitative image analysis workflows for a multi-site laboratory.

Register Here

PRESENTERS

Eric Runde
Principal Product Manager – Clinical
Indica Labs

Sally S. Agersborg, MD, PhD
Medical Director (Aliso Viejo, California)
Neogenomics Laboratories

ABOUT INDICA LABS, INC

Indica Labs is the world’s leading provider of computational pathology software and services. Our flagship HALO® image analysis platform enables fast, quantitative evaluation of tissues using a broad range of artificial intelligence (AI) and computer vision algorithms. HALO Link™ and HALO AP™ facilitate remote image analysis, collaboration and management. Through a combination of precision, performance, scalability, and usability our software solutions enable pharmaceutical companies, diagnostic labs, research organizations, and Indica’s own contract pharma services team to advance tissue-based research, clinical trials, and diagnostics.